# COMPETE-LM Trial: Drug-Coated Balloon-Enhanced Provisional Stenting in Complex Left Main Disease.

Study · id `cardio:ct-nct07408674` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07408674](<https://clinicaltrials.gov/study/NCT07408674>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07408674

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 186 participants.

## Technical summary

Registry record NCT07408674. Randomized; single masking; primary purpose treatment. Start 2026-04 (anticipated); primary completion 2029-04 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 186 participants (planned count; ClinicalTrials.gov record NCT07408674, source copy `cardio:ctgov-nct07408674-2026-02-13`, retrieved 2026-10-26)
- Planned start: 2026-04 (anticipated) (ClinicalTrials.gov record NCT07408674, source copy `cardio:ctgov-nct07408674-2026-02-13`, retrieved 2026-10-26)
- Primary completion: 2029-04 (anticipated) (ClinicalTrials.gov record NCT07408674, source copy `cardio:ctgov-nct07408674-2026-02-13`, retrieved 2026-10-26)
- Completion: 2029-05 (anticipated) (ClinicalTrials.gov record NCT07408674, source copy `cardio:ctgov-nct07408674-2026-02-13`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07408674-2026-02-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: COMPETE-LM Trial: Drug-Coated Balloon-Enhanced Provisional Stenting in Complex Left Main Disease.
- Acronym: COMPETE-LM
- Condition: Complex Left Main Bifurcation Stenosis
- Condition: Left Main Coronary Artery Stenosis
- Condition: Coronary Bifurcation Stenosis
- Intervention (Device): Angiolite Sirolimus-Eluting Stenting
- Intervention (Device): Essential Pro Paclitaxel Drug-Eluting Balloon
- Lead sponsor: Rede Optimus Hospitalar SA
- Lead sponsor class: NETWORK
- Collaborator: iVascular S.L.U.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Rede Optimus Hospitalar SA (`cardio:org-rede-optimus-hospitalar-sa`)
- Registry lists this organization as a collaborator: iVascular S.L.U. (`cardio:org-ivascular-s-l-u`)

## Provenance

Content hash: 445cb5de4ab221953ef628103ac66fb17413c10ac64e7f791e217e7b4fd5a194
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
